ATE285212T1 - Absorptionsförderer für topische pharmazeutische formulierungen - Google Patents

Absorptionsförderer für topische pharmazeutische formulierungen

Info

Publication number
ATE285212T1
ATE285212T1 AT94930744T AT94930744T ATE285212T1 AT E285212 T1 ATE285212 T1 AT E285212T1 AT 94930744 T AT94930744 T AT 94930744T AT 94930744 T AT94930744 T AT 94930744T AT E285212 T1 ATE285212 T1 AT E285212T1
Authority
AT
Austria
Prior art keywords
pharmaceutical formulations
topical pharmaceutical
absorption promoters
enhancers
dimethylamino
Prior art date
Application number
AT94930744T
Other languages
English (en)
Inventor
Servet Bueyuektimkin
Nadir Bueyuektimkin
Joseph Howard Rytting
Original Assignee
Odontex Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Odontex Inc filed Critical Odontex Inc
Application granted granted Critical
Publication of ATE285212T1 publication Critical patent/ATE285212T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT94930744T 1993-10-07 1994-10-07 Absorptionsförderer für topische pharmazeutische formulierungen ATE285212T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13345493A 1993-10-07 1993-10-07
PCT/US1994/011597 WO1995009590A1 (en) 1993-10-07 1994-10-07 Absorption enhancers for topical pharmaceutical formulations

Publications (1)

Publication Number Publication Date
ATE285212T1 true ATE285212T1 (de) 2005-01-15

Family

ID=22458697

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94930744T ATE285212T1 (de) 1993-10-07 1994-10-07 Absorptionsförderer für topische pharmazeutische formulierungen

Country Status (10)

Country Link
EP (1) EP0746294B1 (de)
CN (1) CN1133465C (de)
AT (1) ATE285212T1 (de)
AU (1) AU7977294A (de)
CA (1) CA2178594C (de)
DE (1) DE69434199T2 (de)
ES (1) ES2233933T3 (de)
PT (1) PT746294E (de)
RU (1) RU2165265C2 (de)
WO (1) WO1995009590A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ295797B6 (cs) * 1997-04-04 2005-11-16 Bochemie, S.R.O. Sloučeniny na bázi derivátů omega-aminokyselin, způsob jejich výroby a jejich použití
DE602004021253D1 (de) * 2003-03-21 2009-07-09 Nexmed Holdings Inc Antimykotischer nagellack und anwendungsverfahren
CN1777429A (zh) 2003-04-02 2006-05-24 尼克美制药控股有限公司 前列腺素组合物和其治疗血管痉挛的应用
US20060275230A1 (en) 2004-12-10 2006-12-07 Frank Kochinke Compositions and methods for treating conditions of the nail unit
AU2005314426A1 (en) 2004-12-10 2006-06-15 Talima Therapeutics, Inc. Compositions and methods for treating conditions of the nail unit
RU2470666C2 (ru) * 2008-02-28 2012-12-27 Торэй Индастриз, Инк. Фармацевтическая композиция для трансназального введения
CN104800147A (zh) * 2008-07-10 2015-07-29 德勒尼克斯治疗股份公司 用于大分子的增强的递送的方法和组合物
CA2745206C (en) * 2008-12-04 2018-09-18 Chongxi Yu High penetration compositions and their applications
RU2633236C2 (ru) 2011-04-07 2017-10-11 Нексмед Холдингс, Инк. Способы и композиции для лечения болезни рейно
DE102013004199A1 (de) * 2012-05-15 2013-11-21 Mika Pharma Gesellschaft Für Die Entwicklung Und Vermarktung Pharmazeutischer Produkte Mbh Pharmazeutische Zusammensetzung
AU2014241396A1 (en) 2013-03-14 2015-09-17 Hallux, Inc. Method of treating infections, diseases or disorders of nail unit

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK243084A (da) * 1983-05-26 1984-11-27 Takeda Chemical Industries Ltd Perkutane farmaceutiske praeparater til udvortes brug
US4732892A (en) * 1985-07-12 1988-03-22 American Home Products Corporation L-α-amino acids as transdermal penetration enhancers
US4808414A (en) * 1986-09-29 1989-02-28 Nelson Research & Development Co. Amide penetration enhancers for transdermal delivery of systemic agents
US4980378A (en) * 1988-06-01 1990-12-25 Odontex, Inc. Biodegradable absorption enhancers
US5082866A (en) * 1988-06-01 1992-01-21 Odontex, Inc. Biodegradable absorption enhancers
JPH06509559A (ja) * 1991-03-19 1994-10-27 セラピューティック　パッチ　リサーチ　エヌ．ブイ． 膜透過エンハンサーとしてのアミノアルコール誘導体組成物及び方法

Also Published As

Publication number Publication date
DE69434199D1 (de) 2005-01-27
RU2165265C2 (ru) 2001-04-20
AU7977294A (en) 1995-05-01
PT746294E (pt) 2005-03-31
CA2178594A1 (en) 1995-04-13
CA2178594C (en) 2008-12-23
ES2233933T3 (es) 2005-06-16
EP0746294A1 (de) 1996-12-11
WO1995009590A1 (en) 1995-04-13
DE69434199T2 (de) 2005-12-29
CN1133465C (zh) 2004-01-07
CN1140983A (zh) 1997-01-22
EP0746294B1 (de) 2004-12-22
EP0746294A4 (de) 1998-04-22

Similar Documents

Publication Publication Date Title
ATE285212T1 (de) Absorptionsförderer für topische pharmazeutische formulierungen
DE69229098D1 (de) Hochdosierte topische Kollagenaseformen
LV11279A (lv) Farmaceitiska kompozicija kas satur nervu augsanas faktoru
ATE202476T1 (de) Pharmazeutische zusammensetzungen mit verbesserter perkutaner absorption für piroxicam
DE69919594D1 (de) Topische zusammensetzungen zur prostaglandin e1 abgabe
ES2075011T3 (es) Uso de sales del acido gamma-hidroxibutirico para preparar composiciones farmaceuticas para uso en el tratamiento del alcoholismo, y las composiciones obtenidas.
CO4750836A1 (es) Nuevos medicamentos y utilizacion (1-metiletil)-8-azoniabiciclo-[3.2.1]octnao y su uso en pre- paraciones medicas
MX9304710A (es) Composicion farmaceutica y/o cosmetica y su uso.
DE69332350D1 (de) Verwendung von Lycopen zur Verminderung der Zellaktivität, insbesondere von Krebszellen, sowie entsprechende pharmazeutische Zubereitungen
BR9403783A (pt) Uso de uma composição cosmética
ES2028796T3 (es) Procedimiento para producir preparados farmaceuticos que contienen interferon alfa.
ATE94765T1 (de) Pharmazeutische praeparate zur verbesserten resorption antibakterieller verbindungen.
IT1264856B1 (it) Composizione farmaceutica ad attivita' analgesica
NO934107D0 (no) Penetrasjonsfremmende substans
BR9808215A (pt) Preparados de adesivos para lacas, sua preparação e emprego
DE69012031D1 (de) Optisch aktive Benzylalkoholverbindung und pharmazeutische Zusammensetzung.
ES2078256T3 (es) Formula farmaceutica para uso topico que contiene diclofenaco sodico.
DE3881254D1 (de) Pharmazeutische zusammensetzung.
ATE102934T1 (de) Fluorierte flavon-essigsaeure.
TR199701463T1 (en) Sorbin asiti i�eren hidrojel.
IT8848562A0 (it) Preparazioni farmaceutiche per uso topico a base di eparina, eparinoidi e frazioni, lnw eparina e vlmweparina dotate di elevato assorbimento transdermico per la presenza di esteri di colina
MX9205702A (es) Composicion que comprende un material de tramadol y acetaminofen y su uso.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0746294

Country of ref document: EP